Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$0.13 - $0.46 $64,436 - $228,005
495,665 New
495,665 $71,000
Q1 2022

May 17, 2022

SELL
$0.34 - $0.58 $63,671 - $108,616
-187,269 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$0.54 - $2.51 $67,456 - $313,549
124,920 Added 200.36%
187,269 $100,000
Q3 2021

Nov 12, 2021

BUY
$1.54 - $3.04 $96,017 - $189,540
62,349 New
62,349 $105,000
Q2 2021

Sep 17, 2021

SELL
$2.2 - $3.2 $152,383 - $221,648
-69,265 Closed
0 $0
Q1 2021

May 19, 2021

BUY
$2.08 - $5.26 $109,963 - $278,080
52,867 Added 322.4%
69,265 $177,000
Q4 2020

Feb 24, 2021

BUY
$1.89 - $2.48 $30,992 - $40,667
16,398 New
16,398 $34,000

About Aditxt, Inc.


  • Ticker ADTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,161,130
  • Market Cap $749K
  • Description
  • Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...
More about ADTX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.